Allurion gives notice of voluntary NYSE withdrawal

The notice identifies both common stock and warrants; each whole warrant is exercisable to purchase 0.056818 shares at $202.50 per share.

Rhea-AI Filing Summary

Allurion Technologies, Inc. (ALUR) is the issuer named in a Form 25 notification of removal of its common stock and warrants from listing and/or registration on the New York Stock Exchange. The notice states that the issuer complied with exchange rules and requirements governing voluntary withdrawal. Each whole warrant is exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share.

Key Figures

Warrant share entitlement: 0.056818 shares Warrant exercise price: $202.50 per share

2 metrics

Warrant share entitlement 0.056818 shares Per whole warrant

Warrant exercise price $202.50 per share For each whole warrant

Key Terms

removal from listing and/or registration, voluntary withdrawal, exercise price, whole warrant

4 terms

removal from listing and/or registration regulatory

"NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

voluntary withdrawal regulatory

"governing the voluntary withdrawal of the class"

exercise price financial

"at an exercise price of $202.50 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

whole warrant financial

"each whole warrant exercisable to purchase"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What securities does the ALUR Form 25 notice identify?

The notice identifies Allurion Technologies common stock and warrants for removal from listing and/or registration on the New York Stock Exchange.

What are the exercise terms for ALUR warrants?

Each whole warrant is exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 11:03 AM EDT Accepted by SEC EDGAR 10/13/2026 - 11:03 AM EDT Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-41767

Issuer:	ALLURION TECHNOLOGIES, INC.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	11 HURON DR STE 200
	NATICK	MASSACHUSETTS	01760
Telephone number:					508-647-4000

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock; Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-10-13	By	Anthony Sozzi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.